Search research articles
Contact Us
Filters
Showing results (41-50 of 96) with videos related to
Page
of 10
Sort By:
EXCLI Journal
|
July 25, 2019
Successful palliative peptide receptor radionuclide therapy for impending compression of vena cava due to unresectable liver metastasis of neuroendocrine tumor
Bahar Ataeinia, Christina Loberg, Hanna Kravets, et al.
Nuclear Medicine Communications
|
August 1, 2015
Comparison of automatic versus manual procedures for the quantification of dopamine D2 receptor availability using I-123-IBZM-SPECT
Alexander Heinzel, Siamak Mohammadkhani Shali, Manuel Dafotakis, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 31, 2019
<sup>68</sup>Ga-PSMA PET/CT for monitoring response to <sup>177</sup>Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
Alexander Heinzel, Dima Boghos, Felix M Mottaghy, et al.
Human Brain Mapping
|
December 24, 2005
Affective judgment and beneficial decision making: ventromedial prefrontal activity correlates with performance in the Iowa Gambling Task
Georg Northoff, Simone Grimm, Heinz Boeker, et al.
Nuklearmedizin. Nuclear Medicine
|
March 15, 2018
Relevant tumor sink effect in prostate cancer patients receiving 177Lu-PSMA-617 radioligand therapy
Christian Filss, Alexander Heinzel, Berthold Miiller, et al.
Neuroscience Letters
|
May 12, 2009
Segregated neural representation of psychological and somatic-vegetative symptoms in severe major depression
Alexander Heinzel, Simone Grimm, Johannes Beck, et al.
Neuroreport
|
September 3, 2010
Differential modulation of valence and arousal in high-alexithymic and low-alexithymic individuals
Alexander Heinzel, Ralf Schäfer, Hans-Wilhelm Müller, et al.
Cancers
|
September 23, 2022
Body Composition as a Predictor of the Survival in Anal Cancer
Ahmed Allam Mohamed, Kathrin Risse, Jennifer Stock, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 21, 2013
The use of O-(2-18F-fluoroethyl)-L-tyrosine PET for treatment management of bevacizumab and irinotecan in patients with recurrent high-grade glioma: a cost-effectiveness analysis
Alexander Heinzel, Dirk Müller, Karl-Josef Langen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 18, 2014
Maximum dose rate is a determinant of hypothyroidism after 131I therapy of Graves' disease but the total thyroid absorbed dose is not
Thomas Krohn, Heribert Hänscheid, Berthold Müller, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 96) with videos related to
Sort By:
Page
of 10
EXCLI Journal
|
July 25, 2019
Successful palliative peptide receptor radionuclide therapy for impending compression of vena cava due to unresectable liver metastasis of neuroendocrine tumor
Bahar Ataeinia, Christina Loberg, Hanna Kravets, et al.
Nuclear Medicine Communications
|
August 1, 2015
Comparison of automatic versus manual procedures for the quantification of dopamine D2 receptor availability using I-123-IBZM-SPECT
Alexander Heinzel, Siamak Mohammadkhani Shali, Manuel Dafotakis, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 31, 2019
<sup>68</sup>Ga-PSMA PET/CT for monitoring response to <sup>177</sup>Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
Alexander Heinzel, Dima Boghos, Felix M Mottaghy, et al.
Human Brain Mapping
|
December 24, 2005
Affective judgment and beneficial decision making: ventromedial prefrontal activity correlates with performance in the Iowa Gambling Task
Georg Northoff, Simone Grimm, Heinz Boeker, et al.
Nuklearmedizin. Nuclear Medicine
|
March 15, 2018
Relevant tumor sink effect in prostate cancer patients receiving 177Lu-PSMA-617 radioligand therapy
Christian Filss, Alexander Heinzel, Berthold Miiller, et al.
Neuroscience Letters
|
May 12, 2009
Segregated neural representation of psychological and somatic-vegetative symptoms in severe major depression
Alexander Heinzel, Simone Grimm, Johannes Beck, et al.
Neuroreport
|
September 3, 2010
Differential modulation of valence and arousal in high-alexithymic and low-alexithymic individuals
Alexander Heinzel, Ralf Schäfer, Hans-Wilhelm Müller, et al.
Cancers
|
September 23, 2022
Body Composition as a Predictor of the Survival in Anal Cancer
Ahmed Allam Mohamed, Kathrin Risse, Jennifer Stock, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 21, 2013
The use of O-(2-18F-fluoroethyl)-L-tyrosine PET for treatment management of bevacizumab and irinotecan in patients with recurrent high-grade glioma: a cost-effectiveness analysis
Alexander Heinzel, Dirk Müller, Karl-Josef Langen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 18, 2014
Maximum dose rate is a determinant of hypothyroidism after 131I therapy of Graves' disease but the total thyroid absorbed dose is not
Thomas Krohn, Heribert Hänscheid, Berthold Müller, et al.
Page
of 10